- Home
- Publications
- Publication Search
- Publication Details
Title
Neo-Antigen mRNA Vaccines
Authors
Keywords
-
Journal
Vaccines
Volume 8, Issue 4, Pages 776
Publisher
MDPI AG
Online
2020-12-19
DOI
10.3390/vaccines8040776
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Computational Prediction and Validation of Tumor-Associated Neoantigens
- (2020) Vladimir Roudko et al. Frontiers in Immunology
- TriMix and tumor antigen mRNA electroporated dendritic cell vaccination plus ipilimumab: link between T-cell activation and clinical responses in advanced melanoma
- (2020) Brenda De Keersmaecker et al. Journal for ImmunoTherapy of Cancer
- Mass Spectrometry-Based Identification of MHC-Associated Peptides
- (2020) Sachin Kote et al. Cancers
- Therapeutic Cancer Vaccination with Ex Vivo RNA-Transfected Dendritic Cells—An Update
- (2020) Jan Dörrie et al. Pharmaceutics
- Priming the tumor immune microenvironment with chemo(radio)therapy: A systematic review across tumor types
- (2020) Tom van den Ende et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- A randomized controlled phase II clinical trial on mRNA electroporated autologous monocyte-derived dendritic cells (TriMixDC-MEL) as adjuvant treatment for stage III/IV melanoma patients who are disease-free following the resection of macrometastases
- (2020) Yanina Jansen et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Impact of mRNA chemistry and manufacturing process on innate immune activation
- (2020) Jennifer Nelson et al. Science Advances
- Progress in Neoantigen Targeted Cancer Immunotherapies
- (2020) Xue-Jiao Han et al. Frontiers in Cell and Developmental Biology
- Combination therapies utilizing neoepitope-targeted vaccines
- (2020) Karin L. Lee et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction
- (2020) Daniel K. Wells et al. CELL
- mRNA Vaccine Era—Mechanisms, Drug Platform and Clinical Prospection
- (2020) Shuqin Xu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Selecting Target Antigens for Cancer Vaccine Development
- (2020) Luigi Buonaguro et al. Vaccines
- Shared Immunogenic Poly-Epitope Frameshift Mutations in Microsatellite Unstable Tumors
- (2020) Vladimir Roudko et al. CELL
- Segmented poly(A) tails significantly reduce recombination of plasmid DNA without affecting mRNA translation efficiency or half-life
- (2019) Zeljka Trepotec et al. RNA
- T cell antigen discovery via signaling and antigen-presenting bifunctional receptors
- (2019) Alok V. Joglekar et al. NATURE METHODS
- Deciphering CD4+ T cell specificity using novel MHC–TCR chimeric receptors
- (2019) Jan Kisielow et al. NATURE IMMUNOLOGY
- Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery
- (2019) Piotr S. Kowalski et al. MOLECULAR THERAPY
- Broadening the Message: A Nanovaccine Co-loaded with Messenger RNA and α-GalCer Induces Antitumor Immunity through Conventional and Natural Killer T Cells
- (2019) Rein Verbeke et al. ACS Nano
- Neoantigen identification strategies enable personalized immunotherapy in refractory solid tumors
- (2019) Fangjun Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- A Facile Method for the Removal of dsRNA Contaminant from In Vitro-Transcribed mRNA
- (2019) Markus Baiersdörfer et al. Molecular Therapy-Nucleic Acids
- A library of Neo Open Reading Frame peptides (NOPs) as a sustainable resource of common neoantigens in up to 50% of cancer patients
- (2019) Jan Koster et al. Scientific Reports
- Three decades of messenger RNA vaccine development
- (2019) Rein Verbeke et al. Nano Today
- Toward in silico Identification of Tumor Neoantigens in Immunotherapy
- (2019) Chi Zhou et al. TRENDS IN MOLECULAR MEDICINE
- Best practices for bioinformatic characterization of neoantigens for clinical utility
- (2019) Megan M. Richters et al. Genome Medicine
- Single Domain Antibody-Mediated Blockade of Programmed Death-Ligand 1 on Dendritic Cells Enhances CD8 T-cell Activation and Cytokine Production
- (2019) Broos et al. Vaccines
- Developing neoantigen-targeted T cell–based treatments for solid tumors
- (2019) Tori N. Yamamoto et al. NATURE MEDICINE
- Application of mass spectrometry-based MHC immunopeptidome profiling in neoantigen identification for tumor immunotherapy
- (2019) Xiaomei Zhang et al. BIOMEDICINE & PHARMACOTHERAPY
- Mutation-derived Neoantigen-specific T-cell Responses in Multiple Myeloma
- (2019) Deepak Perumal et al. CLINICAL CANCER RESEARCH
- IDENTIFICATION OF MHC PEPTIDES USING MASS SPECTROMETRY FOR NEOANTIGEN DISCOVERY AND CANCER VACCINE DEVELOPMENT
- (2019) Rui Chen et al. MASS SPECTROMETRY REVIEWS
- Purification of mRNA encoding chimeric antigen receptor is critical for generation of robust T cell response
- (2018) Jessica Bobula Foster et al. HUMAN GENE THERAPY
- mRNA vaccines — a new era in vaccinology
- (2018) Norbert Pardi et al. NATURE REVIEWS DRUG DISCOVERY
- Comparison of the MHC I Immunopeptidome Repertoire of B-Cell Lymphoblasts Using Two Isolation Methods
- (2018) Joël Lanoix et al. PROTEOMICS
- Optimization of mRNA untranslated regions for improved expression of therapeutic mRNA
- (2018) Kirtika H. Asrani et al. RNA Biology
- A versatile T cell-based assay to assess therapeutic antigen-specific PD-1-targeted approaches
- (2018) Maarten Versteven et al. Oncotarget
- The Mutation-Associated Neoantigen Functional Expansion of Specific T Cells (MANAFEST) Assay: A Sensitive Platform for Monitoring Antitumor Immunity
- (2018) Ludmila Danilova et al. Cancer Immunology Research
- Dendritic Cell Targeting mRNA Lipopolyplexes Combine Strong Antitumor T-Cell Immunity with Improved Inflammatory Safety
- (2018) Kevin Van der Jeught et al. ACS Nano
- Cancer Neoantigens
- (2018) Ton N. Schumacher et al. Annual Review of Immunology
- Actively personalized vaccination trial for newly diagnosed glioblastoma
- (2018) Norbert Hilf et al. NATURE
- Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
- (2018) Derin B. Keskin et al. NATURE
- Deep learning using tumor HLA peptide mass spectrometry datasets improves neoantigen identification
- (2018) Brendan Bulik-Sullivan et al. NATURE BIOTECHNOLOGY
- Co-delivery of nucleoside-modified mRNA and TLR agonists for cancer immunotherapy: Restoring the immunogenicity of immunosilent mRNA
- (2017) Rein Verbeke et al. JOURNAL OF CONTROLLED RELEASE
- Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
- (2017) Ugur Sahin et al. NATURE
- Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer
- (2017) Vinod P. Balachandran et al. NATURE
- Antigen presentation profiling reveals recognition of lymphoma immunoglobulin neoantigens
- (2017) Michael S. Khodadoust et al. NATURE
- An immunogenic personal neoantigen vaccine for patients with melanoma
- (2017) Patrick A. Ott et al. NATURE
- Modulating Cytotoxic Effector Functions by Fc Engineering to Improve Cancer Therapy
- (2017) Christian Kellner et al. TRANSFUSION MEDICINE AND HEMOTHERAPY
- Neoantigen Vaccines Pass the Immunogenicity Test
- (2017) Gerald P. Linette et al. TRENDS IN MOLECULAR MEDICINE
- Type I Interferons Modulate CD8 + T Cell Immunity to mRNA Vaccines
- (2017) Ans De Beuckelaer et al. TRENDS IN MOLECULAR MEDICINE
- Arginine-Rich Peptide-Based mRNA Nanocomplexes Efficiently Instigate Cytotoxic T Cell Immunity Dependent on the Amphipathic Organization of the Peptide
- (2017) Vimal K. Udhayakumar et al. Advanced Healthcare Materials
- The neoepitope landscape in pediatric cancers
- (2017) Ti-Cheng Chang et al. Genome Medicine
- Identification and Characterization of Neoantigens As Well As Respective Immune Responses in Cancer Patients
- (2017) Eva Bräunlein et al. Frontiers in Immunology
- Natural Killer T Cells in Cancer Immunotherapy
- (2017) Shiny Nair et al. Frontiers in Immunology
- Mass spectrometry-based antigen discovery for cancer immunotherapy
- (2016) Michal Bassani-Sternberg et al. CURRENT OPINION IN IMMUNOLOGY
- Evading innate immunity in nonviral mRNA delivery: don’t shoot the messenger
- (2016) Joke Devoldere et al. DRUG DISCOVERY TODAY
- Phase II Study of Autologous Monocyte-Derived mRNA Electroporated Dendritic Cells (TriMixDC-MEL) Plus Ipilimumab in Patients With Pretreated Advanced Melanoma
- (2016) Sofie Wilgenhof et al. JOURNAL OF CLINICAL ONCOLOGY
- Type I Interferons Interfere with the Capacity of mRNA Lipoplex Vaccines to Elicit Cytolytic T Cell Responses
- (2016) Ans De Beuckelaer et al. MOLECULAR THERAPY
- Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy
- (2016) Lena M. Kranz et al. NATURE
- Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients
- (2016) Alena Gros et al. NATURE MEDICINE
- High-sensitivity HLA class I peptidome analysis enables a precise definition of peptide motifs and the identification of peptides from cell lines and patients’ sera
- (2016) Danilo Ritz et al. PROTEOMICS
- Targeting of cancer neoantigens with donor-derived T cell receptor repertoires
- (2016) E. Stronen et al. SCIENCE
- Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry
- (2016) Michal Bassani-Sternberg et al. Nature Communications
- Use of HLA peptidomics and whole exome sequencing to identify human immunogenic neo-antigens
- (2016) Shelly Kalaora et al. Oncotarget
- Particle-mediated Intravenous Delivery of Antigen mRNA Results in Strong Antigen-specific T-cell Responses Despite the Induction of Type I Interferon
- (2016) Katrijn Broos et al. Molecular Therapy-Nucleic Acids
- Biomarkers in Cancer Immunotherapy
- (2015) Ton N. Schumacher et al. CANCER CELL
- Dendritic cells transfected with heat-shock protein 70 messenger RNA for patients with hepatitis C virus-related hepatocellular carcinoma: a phase 1 dose escalation clinical trial
- (2015) Yoshinari Maeda et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Mass Spectrometry of Human Leukocyte Antigen Class I Peptidomes Reveals Strong Effects of Protein Abundance and Turnover on Antigen Presentation
- (2015) Michal Bassani-Sternberg et al. MOLECULAR & CELLULAR PROTEOMICS
- Sequence-engineered mRNA Without Chemical Nucleoside Modifications Enables an Effective Protein Therapy in Large Animals
- (2015) Andreas Thess et al. MOLECULAR THERAPY
- Mutant MHC class II epitopes drive therapeutic immune responses to cancer
- (2015) Sebastian Kreiter et al. NATURE
- Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients
- (2015) Duane A. Mitchell et al. NATURE
- Human CD4+ T cells spontaneously detect somatic mutations in cancer cells
- (2015) Willem W Overwijk NATURE MEDICINE
- Neoantigens in cancer immunotherapy
- (2015) T. N. Schumacher et al. SCIENCE
- Immunogenicity of somatic mutations in human gastrointestinal cancers
- (2015) E. Tran et al. SCIENCE
- A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells
- (2015) B. M. Carreno et al. SCIENCE
- Intratumoral Delivery of TriMix mRNA Results in T-cell Activation by Cross-Presenting Dendritic Cells
- (2015) S. Van Lint et al. Cancer Immunology Research
- Intranodal vaccination with mRNA-optimized dendritic cells in metastatic melanoma patients
- (2015) Kalijn F Bol et al. OncoImmunology
- Clinical research of genetically modified dendritic cells in combination with cytokine-induced killer cell treatment in advanced renal cancer
- (2014) Danhong Wang et al. BMC CANCER
- Long-term clinical outcome of melanoma patients treated with messenger RNA-electroporated dendritic cell therapy following complete resection of metastases
- (2014) Sofie Wilgenhof et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Optimized dendritic cell-based immunotherapy for melanoma: the TriMix-formula
- (2014) Sandra Van Lint et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The ReNAissanCe of mRNA-based cancer therapy
- (2014) Sandra Van Lint et al. Expert Review of Vaccines
- mRNA-based dendritic cell vaccines
- (2014) Daphné Benteyn et al. Expert Review of Vaccines
- The potential of antigen and TriMix sonoporation using mRNA-loaded microbubbles for ultrasound-triggered cancer immunotherapy
- (2014) Heleen Dewitte et al. JOURNAL OF CONTROLLED RELEASE
- Adoptive immunotherapy with MUC1-mRNA transfected dendritic cells and cytotoxic lymphocytes plus gemcitabine for unresectable pancreatic cancer
- (2014) Yoshitaro Shindo et al. Journal of Translational Medicine
- Nanoparticle design to induce tumor immunity and challenge the suppressive tumor microenvironment
- (2014) Heleen Dewitte et al. Nano Today
- Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing
- (2014) Mahesh Yadav et al. NATURE
- Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
- (2014) Alexandra Snyder et al. NEW ENGLAND JOURNAL OF MEDICINE
- Diagnostic Clinical Genome and Exome Sequencing
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- Cancer Immunotherapy Based on Mutation-Specific CD4+ T Cells in a Patient with Epithelial Cancer
- (2014) E. Tran et al. SCIENCE
- CD4 T-cell Subsets and Tumor Immunity: The Helpful and the Not-so-Helpful
- (2014) H.-J. Kim et al. Cancer Immunology Research
- Molecular mimicry of MAGE-A6 andMycoplasma penetransHF-2 epitopes in the induction of antitumor CD8+T-cell responses
- (2014) Lazar Vujanovic et al. OncoImmunology
- A phase IB study on intravenous synthetic mRNA electroporated dendritic cell immunotherapy in pretreated advanced melanoma patients
- (2013) S. Wilgenhof et al. ANNALS OF ONCOLOGY
- A comparative analysis of algorithms for somatic SNV detection in cancer
- (2013) Nicola D. Roberts et al. BIOINFORMATICS
- Immunogenicity of dendritic cells pulsed with MAGE3, Survivin and B-cell maturation antigen mRNA for vaccination of multiple myeloma patients
- (2013) Willemijn Hobo et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Melanoma immunotherapy using mature DCs expressing the constitutive proteasome
- (2013) Jens Dannull et al. JOURNAL OF CLINICAL INVESTIGATION
- Innate immune response and programmed cell death following carrier-mediated delivery of unmodified mRNA to respiratory cells
- (2013) Oliwia Andries et al. JOURNAL OF CONTROLLED RELEASE
- Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells
- (2013) Paul F Robbins et al. NATURE MEDICINE
- RNA: The new revolution in nucleic acid vaccines
- (2013) Andrew J. Geall et al. SEMINARS IN IMMUNOLOGY
- A novel, disruptive vaccination technology
- (2013) Karl-Josef Kallen et al. Human Vaccines & Immunotherapeutics
- Exploiting the Mutanome for Tumor Vaccination
- (2012) J. C. Castle et al. CANCER RESEARCH
- Preclinical Evaluation of TriMix and Antigen mRNA-Based Antitumor Therapy
- (2012) S. Van Lint et al. CANCER RESEARCH
- Vaccination with mRNA-Electroporated Dendritic Cells Induces Robust Tumor Antigen-Specific CD4+ and CD8+ T Cells Responses in Stage III and IV Melanoma Patients
- (2012) E. H. J. G. Aarntzen et al. CLINICAL CANCER RESEARCH
- The cancer antigenome
- (2012) Bianca Heemskerk et al. EMBO JOURNAL
- Insights into the processing of MHC class I ligands gained from the study of human tumor epitopes
- (2011) Nathalie Vigneron et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- mRNA: delivering an antitumor message?
- (2011) Sandra Van Lint et al. Immunotherapy
- Therapeutic Vaccination With an Autologous mRNA Electroporated Dendritic Cell Vaccine in Patients With Advanced Melanoma
- (2011) Sofie Wilgenhof et al. JOURNAL OF IMMUNOTHERAPY
- Expression of therapeutic proteins after delivery of chemically modified mRNA in mice
- (2011) Michael S D Kormann et al. NATURE BIOTECHNOLOGY
- Ribose 2′-O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5
- (2011) Roland Züst et al. NATURE IMMUNOLOGY
- Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA
- (2011) Katalin Karikó et al. NUCLEIC ACIDS RESEARCH
- Intranodal Vaccination with Naked Antigen-Encoding RNA Elicits Potent Prophylactic and Therapeutic Antitumoral Immunity
- (2010) S. Kreiter et al. CANCER RESEARCH
- Tumor-reactive CD4+T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts
- (2010) Sergio A. Quezada et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Induction of complete and molecular remissions in acute myeloid leukemia by Wilms' tumor 1 antigen-targeted dendritic cell vaccination
- (2010) V. F. Van Tendeloo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- In situ Expression of Tumor Antigens by Messenger RNA-Electroporated Dendritic Cells in Lymph Nodes of Melanoma Patients
- (2009) D. H. Schuurhuis et al. CANCER RESEARCH
- Direct Injection of Protamine-protected mRNA: Results of a Phase 1/2 Vaccination Trial in Metastatic Melanoma Patients
- (2009) Benjamin Weide et al. JOURNAL OF IMMUNOTHERAPY
- Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability
- (2008) Katalin Karikó et al. MOLECULAR THERAPY
- Treatment of Metastatic Melanoma with Autologous CD4+ T Cells against NY-ESO-1
- (2008) Naomi N. Hunder et al. NEW ENGLAND JOURNAL OF MEDICINE
- MHC class I assembly: out and about
- (2008) Malini Raghavan et al. TRENDS IN IMMUNOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now